Concepedia

Robert N. Schuck

RN

Statistics

Publications

20

Citations

1.2K

H-Index

18

Active since

2008

Affiliations

University of North Carolina at Chapel Hill(Current)

Center for Drug Evaluation and Research

National Institute of Environmental Health Sciences

National Institutes of Health

United States Food and Drug Administration

Robert N. Schuck is an author at University of North Carolina at Chapel Hill specializing in pharmacology, medicine, and clinical pharmacology.

ORCID

Publications per year

2008–2024

20

Publications

20

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 164 citations

, , +17

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

Yangmei Deng, Matthew L. Edin, Katherine N. Theken et al. · The FASEB Journal · 2010 · 133 citations

, , +17

Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease

Katherine N. Theken, Robert N. Schuck, Matthew L. Edin et al. · Atherosclerosis · 2012 · 108 citations

, , +12

The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease

Robert N. Schuck, Weibin Zha, Matthew L. Edin et al. · PLoS ONE · 2014 · 95 citations · Full text

, , +17

Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity

Weibin Zha, Matthew L. Edin, Kimberly C. Vendrov et al. · Journal of Lipid Research · 2014 · 87 citations · Full text

, , +17

1–5 of 20